Finance

Lists
Q3 2026 earnings • in 5 days
See details
MIST:NASDAQ
Milestone Pharmaceuticals Inc
0,76 $
+10,15%
(+0,070) 1D
0,76 $
-0,37% (-0,0028)
After hours
Closed: 6 նոյ, 16:00:01 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MIST...
Open
0,72 $
High
0,77 $
Low
0,70 $
Mkt. cap
95,31 մլն
Avg. vol.
924,50 հզր
Volume
556,42 հզր
52-wk high
3,06 $
52-wk low
0,63 $
EPS
-0,69 $
Beta
1,07
Shares outstanding
124,50 մլն
No. of employees
38
Open
0,72 $
High
0,77 $
Low
0,70 $
Mkt. cap
95,31 մլն
Avg. vol.
924,50 հզր
Volume
556,42 հզր
52-wk high
3,06 $
52-wk low
0,63 $
EPS
-0,69 $
Beta
1,07
Shares outstanding
124,50 մլն
No. of employees
38
News stories
From web sources and news partners
About Milestone Pharmaceuticals Inc
CEO-
Employees38
Founded2003
Headquarters-
SectorHealth Care
Industry-
Websitemilestonepharma.com
Analyst ratings
Based on 5 analysts giving stock ratings to MIST in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for MIST in the last 3 months.
Highest
Current 0,76 $
8,00 $ (+948,77%)
Average
6,20 $ (+712,79%)
Lowest
3,00 $ (+293,29%)
Analyst
Recommendation
Action
Price target
Projected
Date
Tiago Fauth
Raymond James
Buy
Maintained
5,00 $
+555,5%
10/20/2026
Brandon Folkes
H.C. Wainwright
Buy
Maintained
8,00 $
+948,8%
09/21/2026
Olivia Brayer
Cantor Fitzgerald
Buy
Initiated
3,00 $
+293,3%
08/20/2026
Ritu Baral
TD Cowen
Buy
Maintained
8,00 $
+948,8%
08/12/2026
Mohit Bansal
Wells Fargo
Buy
Maintained
7,00 $
+817,7%
08/13/2026
Edward Tenthoff
Piper Sandler
Buy
Reiterated
7,00 $
+817,7%
05/14/2026
Unknown Analyst
Raymond James
Buy
Initiated
6,00 $
+686,6%
04/09/2026
Next call 5 օրից
նոյ 13, ուր, 15:30
Fiscal period
Q3 2026
- / -0,21 $
Revenue / Est. (USD)
- / 1,00 մլն
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
1,55 մլն
238,00 հզր
559,00 հզր
Cost of goods sold
-
-
14,00 հզր
32,00 հզր
Cost of revenue
-
-
14,00 հզր
32,00 հզր
Research and development expenses
3,94 մլն
5,52 մլն
3,25 մլն
3,51 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7,89 մլն
13,28 մլն
20,64 մլն
22,65 մլն
Operating expense
11,83 մլն
18,80 մլն
23,89 մլն
26,16 մլն
Total operating expenses
11,83 մլն
18,80 մլն
23,90 մլն
26,19 մլն
Operating income
-11,83 մլն
-17,26 մլն
-23,66 մլն
-25,63 մլն
Other non operating income
-
-
-
-
EBT including unusual items
-11,92 մլն
-17,41 մլն
-26,07 մլն
-28,61 մլն
EBT excluding unusual items
-11,92 մլն
-17,41 մլն
-26,07 մլն
-28,61 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-11,92 մլն
-17,41 մլն
-26,07 մլն
-28,61 մլն
Net profit margin
-
-1 126,07%
-10 952,10%
-5 118,78%
Earnings per share
-0,12
-0,15
-0,20
-0,21
Interest and investment income
874,00 հզր
833,00 հզր
1,73 մլն
1,74 մլն
Interest expense
-967,00 հզր
-985,00 հզր
-4,14 մլն
-4,72 մլն
Net interest expenses
-93,00 հզր
-152,00 հզր
-2,40 մլն
-2,98 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-11,80 մլն
-17,22 մլն
-23,61 մլն
-25,57 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps